| P2093 | author name string | Rudd RM | |
| | Roland M | |
| P2860 | cites work | A genetic model for colorectal tumorigenesis | Q27860582 |
| | The clonal evolution of tumor cell populations | Q28271546 |
| | p53-dependent apoptosis modulates the cytotoxicity of anticancer agents | Q29615031 |
| | Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung | Q30502393 |
| | C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. | Q34124421 |
| | Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia | Q35798342 |
| | Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. | Q36745519 |
| | Molecular damage in the bronchial epithelium of current and former smokers | Q37541079 |
| | Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. | Q38339027 |
| | Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers | Q38480210 |
| | Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas | Q38480548 |
| | Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma | Q38481338 |
| | A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. | Q38481941 |
| | The natural history of lung cancer: A review based on rates of tumour growth | Q39898571 |
| | Molecular and biological factors in the prognosis of non-small cell lung cancer | Q40376628 |
| | Genetic changes in the development of lung cancer | Q40648205 |
| | New prognostic factors in resectable non-small cell lung cancer | Q41023437 |
| | Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977 | Q41046927 |
| | bcl-2 protein in non-small-cell lung carcinoma | Q42508274 |
| | Delays in the management of lung cancer | Q43043765 |
| | Hereditary cancer, oncogenes, and antioncogenes. | Q43856656 |
| | Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study | Q50583436 |
| | Field cancerization in the aerodigestive tract--its etiology, manifestation, and significance. | Q50923938 |
| | Mortality in relation to smoking: 20 years' observations on male British doctors | Q55032900 |
| | Patterns of Absolute Risk of Lung Cancer Mortality in Former Smokers | Q57941783 |
| | L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer | Q59081169 |
| | Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung | Q68082107 |
| | The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern | Q68258204 |
| | K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung | Q68532141 |
| | Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer | Q69373028 |
| | Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung | Q69855061 |
| | Gene amplification of c-myc and N-myc in small cell carcinoma of the lung | Q70143171 |
| | Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct | Q70646171 |
| | Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device | Q70737116 |
| | Sequential molecular genetic changes in lung cancer development | Q70851318 |
| | Clonal evolution of lung tumors | Q71006106 |
| | Importance of chromosome 9p loss in human lung cancer | Q71751760 |
| | Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model | Q72198415 |
| | Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma | Q72365281 |
| | Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study | Q72395824 |
| | Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study | Q72395827 |
| | Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma | Q72611044 |
| | The smoking gun and the damage done: genetic alterations in the lungs of smokers | Q73443304 |
| | Clonal genetic alterations in the lungs of current and former smokers | Q73443322 |
| | The natural history of cancer | Q78279830 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 979-983 | |
| P577 | publication date | 1998-11-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Genetics and pulmonary medicine. 7. Somatic mutations in the development of lung cancer | |
| P478 | volume | 53 | |